Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4

2009 ◽  
Vol 390 (2) ◽  
pp. 99-107 ◽  
Author(s):  
Maria E. Stensland ◽  
Sylvie Pollmann ◽  
Øyvind Molberg ◽  
Ludvig M. Sollid ◽  
Burkhard Fleckenstein

Abstract Enzymes of the peptidylarginine deiminase (PAD) family catalyze the posttranslational deimination of polypeptide-bound arginine residues. Here, we report the selection of peptide substrates by PAD-4, an isoform thought to be involved in the pathogenesis of rheumatoid arthritis. First, we investigated whether PAD-4-mediated deimination is influenced by the nature of amino acid residues flanking the targeted arginine. Using two peptide substrates, residues in positions -2, -1, +1, and +2 relative to the central arginine targeted by PAD-4 were systematically replaced by all natural l-amino acids except cysteine. Each peptide was treated with recombinant human PAD-4 and deimination was analyzed by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry. In all four flanking positions, amino acids which positively or negatively influenced deimination were identified. We next designed peptides with expected high or low deimination rates and determined their Km and kcat values. These peptides showed PAD-4 substrate behavior as predicted, demonstrating that residues flanking the targeted arginine are important for deimination. Further truncation of peptide substrates suggested additional effects on deimination by residues outside the -2 to +2 region. Finally, we observed that a methylated lysine residue flanking the targeted arginine influences PAD-4-mediated deimination, also suggesting that posttranslational modifications can affect substrate efficiency.

2005 ◽  
Vol 51 (6) ◽  
pp. 989-996 ◽  
Author(s):  
Karin Zurbriggen ◽  
Markus Schmugge ◽  
Marlis Schmid ◽  
Silke Durka ◽  
Peter Kleinert ◽  
...  

Abstract Background: Hemoglobin (Hb) heterogeneity arises mainly from posttranslational modifications of the globin chains, and cation-exchange chromatography reveals falsely increased concentrations of some minor Hbs in the presence of abnormal Hbs. Here we describe a method for identification of the globin chains and their posttranslational modifications contained in the Hb fractions. Methods: We used cation-exchange HPLC (PolyCAT A column) for separation of Hb fractions and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for analysis of the separated globin chains. Globin chains were identified by their molecular masses. Posttranslational modifications of globin chains were identified by digestion of the proteins with endoproteinase V8 before MALDI-TOF MS of the resulting peptides. Results: Analysis of the HbA2 fractions of patients with HbS revealed 4 different globin chains. We found, in addition to the expected α- and δ-chains, the carbamylated α- and the βS-chains. Additionally, we analyzed HbH, Hb Barts, HbA1b, pre-HbA1c, HbA1c, HbF1, HbF, HbA1d3a, HbA1d3b, HbA2, and HbC1 fractions from control and pathologic blood samples. We identified several posttranslational modifications of the globin chains, such as pyruvatization, glycation, acetylation, carbamylation, and acetaldehyde adduct formation. Conclusions: The native and posttranslationally modified globin chains in minor and major Hbs are unambiguously identified by MALDI-TOF MS. A minor Hb containing the carbamylated α- and the βS-chain elutes at the same time as normal HbA2 (α2δ2) and thus leads to falsely increased HbA2 values in patients with HbS when blood is analyzed with PolyCAT A chromatography.


Sign in / Sign up

Export Citation Format

Share Document